Zai Lab to Announce First Quarter 2021 Financial Results on May 10, 2021

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB) has announced it will report its financial results for Q1 2021 before the U.S. market opens on May 10, 2021. Along with the financial update, the company will provide a corporate update during a live conference call and webcast at 8:00 a.m. ET. Interested participants can register online for the event through the provided link. Zai Lab focuses on developing therapies for oncology, autoimmune disorders, and infectious diseases, and aims to impact global health.

Company to Host Conference Call and Webcast on May 10, 2021 at 8:00 a.m. ET

SHANGHAI and SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that it will report financial results for the first quarter ended March 31, 2021, and provide a corporate update before the opening of the U.S. equity markets on May 10, 2021.

Conference Call and Webcast Information

Zai Lab will host a live conference call and webcast on May 10, 2021 at 8:00 a.m. ET. Listeners may access the live webcast by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call. Details are as follows:

Registration Link:	http://apac.directeventreg.com/registration/event/2374839
Conference ID:	2374839

All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will receive a dial-in number, Direct Event passcode, and a unique access PIN, which can be used to join the conference call.

A replay will be available shortly after the call and can be accessed by visiting the Company's website at http://ir.zailaboratory.com.

About Zai Lab

Zai Lab (NASDAQ:ZLAB, HKEX:9688) is an innovative, research-based, commercial-stage biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.
For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006, ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.com

Investors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
prahmer@enduranceadvisors.com / mzanoni@enduranceadvisors.com

Zai Lab Limited

Source: Zai Lab Limited

FAQ

When will Zai Lab report its Q1 2021 financial results?

Zai Lab will report its Q1 2021 financial results on May 10, 2021, before the U.S. market opens.

What time is the Zai Lab conference call on May 10, 2021?

The Zai Lab conference call is scheduled for 8:00 a.m. ET on May 10, 2021.

How can I access the Zai Lab webcast?

You can access the Zai Lab webcast by visiting their website at http://ir.zailaboratory.com.

What is Zai Lab's focus in the biopharmaceutical industry?

Zai Lab focuses on developing and commercializing therapies for oncology, autoimmune disorders, and infectious diseases.